U.S., Aug. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07744074) titled 'Phase I Study of Carbon-Ion Lattice Radiotherapy for Large Thoracic Tumors' on July 13.
Brief Summary: This is the first prospective clinical study to evaluate the efficacy and safety of induction chemoimmunotherapy followed by carbon ion radiotherapy and consolidation immunotherapy in patients with unresectable locally advanced non-small cell lung cancer (NSCLC). Based on this prospective study, tumor tissue, blood, urine, and stool samples from participants will be collected and analyzed to identify predictive markers of treatment response.
Study Start Date: May 26
Study Type: INTERVENTIONAL
Condition:
Carbon Ion Radiotheray
I...